Skip to main content

Table 4 Information reported to clinicians for CF samples

From: Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices

Information included in the laboratory report

No. of centers (%)

Isolated species

17 (100)

Antibiotic susceptibility

17 (100)

Use of different MIC interpretation for inhaled antibioticsa

5 (29)

Total count of microorganisms

3 (18)

Individual count of each species

11 (65)

P. aeruginosa morphotype

16 (94)

P. aeruginosa hypermutable trait

4 (24)

S. aureus SCVs

4 (24)

  1. MICs: Minimal inhibitory concentrations; SCVs: Small-colony variants.
  2. aInhaled tobramycin breakpoints for P. aeruginosa: Susceptible (≤64 μg/mL) or resistant (>64 μg/mL).